Publicacions en què col·labora amb Pedro Enrique Mondejar Lopez (20)

2024

  1. Longitudinal transcriptional immune profiles and persistent wheezing in moderate-to-late preterm infants

    Pediatric Allergy and Immunology, Vol. 35, Núm. 10

2023

  1. SARS-CoV-2 infection in children with cystic fibrosis: A cross-sectional multicenter study in Spain. New waves, new knowledge

    Pediatric Pulmonology, Vol. 58, Núm. 11, pp. 3195-3205

2022

  1. Geographic distribution and phenotype of European people with cystic fibrosis carrying A1006E mutation

    Respiratory Medicine, Vol. 192

2021

  1. Factors associated to functional recovery of left vocal fold motion impairment at two-years-old age in very preterm infants

    International Journal of Pediatric Otorhinolaryngology, Vol. 142

2020

  1. Impact of SARS-CoV-2 infection in patients with cystic fibrosis in Spain: Incidence and results of the national CF-COVID19-Spain survey

    Respiratory Medicine, Vol. 170

  2. Impact of early caffeine therapy in preterm newborns on infant lung function

    Pediatric Pulmonology, Vol. 55, Núm. 1, pp. 102-107

  3. Preschool asthma symptoms in children born preterm: The relevance of lung function in infancy

    Journal of Clinical Medicine, Vol. 9, Núm. 10, pp. 1-8

2018

  1. Bacteria from bronchoalveolar lavage fluid from children with suspected chronic lower respiratory tract infection: results from a multi-center, cross-sectional study in Spain

    European Journal of Pediatrics, Vol. 177, Núm. 2, pp. 181-192

2017

  1. Cystic fibrosis treatment: targeting the basic defect

    Expert Opinion on Orphan Drugs, Vol. 5, Núm. 2, pp. 181-192

  2. R248G cystic fibrosis transmembrane conductance regulator mutation in three siblings presenting with recurrent acute pancreatitis and reproductive issues: a case series

    Journal of Medical Case Reports, Vol. 11, Núm. 1

2016

  1. Seguimiento a largo plazo de un programa de prevención y cesación tabáquica en pacientes con fibrosis quística

    Adicciones: Revista de socidrogalcohol, Vol. 28, Núm. 2, pp. 99-107

2015

  1. Risk factors for bronchiolitis, recurrent wheezing, and related hospitalization in preterm infants during the first year of life

    Pediatric Allergy and Immunology, Vol. 26, Núm. 8, pp. 797-804

2014

  1. Broncoscopia flexible en el estudio del reflujo gastroesofágico

    Broncoscopia pediátrica y técnicas asociadas (Ergon), pp. 197-206

2013

  1. HLA-DRB1 and HLA-DQB1 genes on susceptibility to and protection from allergic bronchopulmonary aspergillosis in patients with cystic fibrosis

    Microbiology and Immunology, Vol. 57, Núm. 3, pp. 193-197

2012

  1. Lung function among infants born preterm, with or without bronchopulmonary dysplasia

    Pediatric Pulmonology, Vol. 47, Núm. 7, pp. 674-681

  2. Smoking prevention and cessation programme in cystic fibrosis: Integrating an environmental health approach

    Journal of Cystic Fibrosis, Vol. 11, Núm. 1, pp. 34-39

2010

  1. Do risk factors for persistent asthma modify lung function in infants and young children with recurrent wheeze?

    Pediatric Pulmonology, Vol. 45, Núm. 9, pp. 914-918

2009

  1. CFTR H609R mutation in Ecuadorian patients with cystic fibrosis

    Journal of Cystic Fibrosis, Vol. 8, Núm. 4, pp. 280-281

  2. CFTR mutations in cystic fibrosis patients from Murcia region (southeastern Spain): Implications for genetic testing

    Clinical Genetics

  3. Is the effect of prenatal paracetamol exposure on wheezing in preschool children modified by asthma in the mother?

    International Archives of Allergy and Immunology, Vol. 149, Núm. 1, pp. 33-37